483
Sun Pharmaceutical Medicare LimitedFDA 483 - Sun Pharmaceutical Medicare Limited - July 13, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Sun Pharmaceutical Medicare Limited, a sterile drug manufacturer in Halol, India, revealed significant deficiencies in their quality control laboratory. The firm failed to adequately investigate numerous "Unsuccessful Logon Attempt" messages in their Empower software audit trail, which is used for drug product testing. This lack of investigation raises concerns about data integrity and unauthorized access to analytical raw data.
Open in Dashboard
ID · a78c96ec-097e-4866-95cf-cdd0be0da582